Literature DB >> 17505151

Control of fatty acid metabolism by leptin in L6 rat myoblasts is regulated by hyperinsulinemia.

M Eguchi1, S Shrivastava, N Lyakhovsky, W Kim, R Palanivel, G Sweeney.   

Abstract

The development of hypothalamic leptin resistance plays a role in the development of obesity, yet whether peripheral leptin resistance occurs in obesity and diabetes is controversial. Here we investigate whether hyperinsulinemia, as observed during the development of Type 2 diabetes, modifies the effects of leptin on long chain fatty acid metabolism in skeletal muscle cells. We used boron dipyrromethene difluoride (BODIPY)-labeled palmitate to show that leptin (60 nM) caused a time-dependent (0-60 min) increase in fatty acid uptake in L6 myoblasts. Quantitative analysis using 3H-palmitate showed that pre-incubation with insulin (100 nM, 24 h) prevented stimulation of fatty acid uptake by leptin. Insulin pre-treatment also attenuated the ability of leptin to phosphorylate acetyl Co-A carboxylase and increase palmitate oxidation. Suppressor of cytokine-3 (SOCS-3) has been proposed as a possible mediator of insulin-induced leptin resistance. Here we show that treatment of L6 cells with insulin elicited a time-dependent increase in both SOCS-3 mRNA and protein content. In summary, hyperinsulinemia can induce leptin resistance in L6 myoblasts and this may be mediated via a SOCS-3-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17505151     DOI: 10.1007/BF03347424

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  39 in total

Review 1.  Obesity and insulin resistance.

Authors:  B B Kahn; J S Flier
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 2.  Longevity, lipotoxicity and leptin: the adipocyte defense against feasting and famine.

Authors:  Roger H Unger
Journal:  Biochimie       Date:  2005-01       Impact factor: 4.079

3.  Hyperglycemia- and hyperinsulinemia-induced alteration of adiponectin receptor expression and adiponectin effects in L6 myoblasts.

Authors:  X Fang; R Palanivel; X Zhou; Y Liu; A Xu; Y Wang; G Sweeney
Journal:  J Mol Endocrinol       Date:  2005-12       Impact factor: 5.098

Review 4.  Lipotoxic diseases.

Authors:  Roger H Unger
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

Review 5.  Lipotoxic diseases of nonadipose tissues in obesity.

Authors:  R H Unger; L Orci
Journal:  Int J Obes Relat Metab Disord       Date:  2000-11

6.  Discordant gene expression in skeletal muscle and adipose tissue of patients with type 2 diabetes: effect of interleukin-6 infusion.

Authors:  A L Carey; E Wolsk Petersen; C R Bruce; R J Southgate; H Pilegaard; J A Hawley; B K Pedersen; M A Febbraio
Journal:  Diabetologia       Date:  2006-03-15       Impact factor: 10.122

Review 7.  Role of candidate genes in the responses to long-term overfeeding: review of findings.

Authors:  O Ukkola; C Bouchard
Journal:  Obes Rev       Date:  2004-02       Impact factor: 9.213

8.  Identification of SOCS-3 as a potential mediator of central leptin resistance.

Authors:  C Bjørbaek; J K Elmquist; J D Frantz; S E Shoelson; J S Flier
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

9.  The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia.

Authors:  G M van der Vleuten; L A Kluijtmans; A Hijmans; H J Blom; A F H Stalenhoef; J de Graaf
Journal:  Int J Obes (Lond)       Date:  2006-06       Impact factor: 5.095

Review 10.  Skeletal muscle stem cells.

Authors:  Jennifer C J Chen; David J Goldhamer
Journal:  Reprod Biol Endocrinol       Date:  2003-11-13       Impact factor: 5.211

View more
  1 in total

Review 1.  Tissue-Specific Effects of Leptin on Glucose and Lipid Metabolism.

Authors:  Sandra Pereira; Daemon L Cline; Maria M Glavas; Scott D Covey; Timothy J Kieffer
Journal:  Endocr Rev       Date:  2021-01-28       Impact factor: 19.871

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.